1598P Xaluritamig, a STEAP1 X CD3 XmAb 2+1 Immune Therapy, in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc): Initial Results from Dose Expansion Cohorts in a Phase I Study
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要